Clinical Trials Using Belinostat
Clinical trials are research studies that involve people. The clinical trials on this list are studying Belinostat. All trials on the list are supported by NCI.
NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out. Clinical trials look at new ways to prevent, detect, or treat disease. You may want to think about taking part in a clinical trial. Talk to your doctor for help in deciding if one is right for you.
Carfilzomib and Belinostat in Treating Patients with Relapsed or Refractory Non-Hodgkin Lymphoma
This phase I trial studies the side effects and best dose of carfilzomib and belinostat when given together in treating patients with non-Hodgkin lymphoma that has returned after a period of improvement (relapsed) or has not responded to previous treatment (refractory). Carfilzomib and belinostat may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
Location: 4 locations
MRSI in Predicting Early Response in Patients Treated with Radiation Therapy and Temozolomide with or without Belinostat for Newly-Diagnosed Glioblastoma or Gliosarcoma
This phase II trial studies magnetic resonance spectroscopic imaging (MRSI) in predicting early response in patients treated with radiation therapy and temozolomide with or without belinostat for newly-diagnosed glioblastoma or gliosarcoma. Diagnostic procedures, such as MRSI, may help doctors predict a patient's response to belinostat, to see how well belinostat works to kill glioblastoma or gliosarcoma cells, and allow doctors to plan better treatment.
Location: 2 locations